BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6262141)

  • 1. Potency test of killed polio vaccines. Statistical analysis of test on chicken and preliminary results in combination with ELISA D-antigen determinations.
    Larbaigt G; Moulin J; Souvras M; Gibelin N; Beranger G
    Dev Biol Stand; 1981; 47():113-8. PubMed ID: 6262141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-antigen determination in polio vaccine production: comparison of gel diffusion and ELISA methods.
    van der Marel P; Hazendonk AG; van Wezel AL
    Dev Biol Stand; 1981; 47():101-8. PubMed ID: 6262140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic potency of inactivated poliovirus vaccines.
    Moynihan M; Petersen I
    Dev Biol Stand; 1981; 47():129-33. PubMed ID: 6262143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
    Sawyer LA; McInnis J; Albrecht P
    Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potency testing of killed polio vaccine in rats.
    van Steenis G; van Wezel AL; Sekhuis VM
    Dev Biol Stand; 1981; 47():119-28. PubMed ID: 6262142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV).
    Rezapkin G; Dragunsky E; Chumakov K
    Biologicals; 2005 Mar; 33(1):17-27. PubMed ID: 15713553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct enzyme linked immunosorbent assay (ELISA) for quantification of poliomyelitis virus D-antigen.
    Souvras M; Montagnon B; Fanget B; van Wezel AL; Hazendonk AG
    Dev Biol Stand; 1980; 46():197-202. PubMed ID: 6244997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of poliovirus antigen measurements in vitro and in small animals.
    von Seefried A; Bryce E; Campbell JB; Chun JH; Laurence GD; Scollard N; Tsai KS
    Dev Biol Stand; 1981; 47():91-100. PubMed ID: 6262165
    [No Abstract]   [Full Text] [Related]  

  • 9. Enzyme-linked immunosorbent assay for detection of poliovirus antigen and antibody.
    Moynihan M; Ladefoged P; Mathiesen L
    Dev Biol Stand; 1980; 46():203-6. PubMed ID: 6244998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies.
    Singer C; Knauert F; Bushar G; Klutch M; Lundquist R; Quinnan GV
    J Biol Stand; 1989 Apr; 17(2):137-50. PubMed ID: 2541133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of 2-phenoxyethanol on potency of Sabin inactivated poliomyelitis vaccine and its safety].
    Bian CX; Jiang SD; Yang JY; Sun MB; Xie MX; Zhang XW; Liao GY; Li WD
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):44-6. PubMed ID: 17429533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A note on single- and two-dose immunogenicity tests of inactive virus vaccine in chicks.
    Slonim D; Drevo M
    J Hyg Epidemiol Microbiol Immunol; 1976; 21(3):368-70. PubMed ID: 1033226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antigenicity determination of inactivated poliovirus--the micro-neutralization inhibition test].
    Jiang SD; Pye D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Aug; 7(4):309-12. PubMed ID: 3011295
    [No Abstract]   [Full Text] [Related]  

  • 14. [An ELISA system based on the specific class Y (IgY) antibodies from egg yolks for the quantitative determination of D-antigen in inactivated poliovirus vaccines].
    Ivanov AP; Kozlov VG; Klebleeva TD; Ivanova OE; Kiktenko AV
    Vopr Virusol; 2014; 59(6):39-42. PubMed ID: 25929036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation and standardization of IPV and IPV combination vaccines.
    Baca-Estrada M; Griffiths E
    Biologicals; 2006 Jun; 34(2):159-61. PubMed ID: 16682221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccine.
    Wood DJ; Heath AB; Kersten GF; Hazendonk T; Lantinga M; Beuvery EC
    Biologicals; 1997 Mar; 25(1):59-64. PubMed ID: 9167009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen content of inactivated Newcastle disease oil emulsion vaccines as an in vitro indicator of potency.
    Maas R; van Diepen M; Komen M; Oei H; Claassen I
    Dev Biol (Basel); 2002; 111():313-8. PubMed ID: 12678255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potency of wild-type or sabin trivalent inactivated poliovirus vaccine, by enzyme-linked immunosorbent assay using monoclonal antibiotics specific for each antigenic site.
    Sawyer LA; Wood D; Ferguson M; Crainic R; Beuvery EC; McInnis J; Albrecht P
    Biologicals; 1997 Sep; 25(3):299-306. PubMed ID: 9324998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ELISA as a possible alternative to the neutralization test for evaluating the immune response to poliovirus vaccines.
    Ivanov AP; Dragunsky EM
    Expert Rev Vaccines; 2005 Apr; 4(2):167-72. PubMed ID: 15889990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring Poliovirus Antigenicity by Surface Plasmon Resonance. Application for Potency Indicating Assays.
    Westdijk J; van der Maas L; Ten Have R; Kersten G
    Methods Mol Biol; 2016; 1387():299-323. PubMed ID: 26983742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.